HealthEconomics.Com – Connected. Community.

Latest Headlines:

MMIT’s Q2 Update to 2021 Directory of Health Plans Now Available
Employer Healthcare Costs Will Increase 5% in 2022 as the COVID-19 Pandemic Continues
Best Buy Acquires Current Health in Healthcare Strategy
Global Tumour Necrosis Factor Inhibitor Drugs Market to be Driven by Prevalence of Several Inflammatory Disorders, and Growing Demand Amongst the Geriatric Population in the Forecast Period of 2021-2026
Genedata has Successfully Collaborated with Egis Pharmaceuticals PLC to Develop a Precision Medicine Tool for Rheumatoid Arthritis
A return to the top: Former FDA Commissioner Califf reportedly Biden's pick for Woodcock's role
Novartis exec says COVID exposed pharma manufacturing weaknesses. Here's how he plans to fix them
Pharma saw huge reputation gains in the last year. It should make sure not to squander them, expert says
New research project aims to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence - ecancer
Clinical CRO Market Trends Shows a Rapid Growth by 2026 | Iqvia, Covance, Syneos Health, Pharmaceutical Product Development?PPD

HEOR Feature

Using RWE to Make Cost Decisions: A New Report

A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world… Read more

Featured

MMIT’s Q2 Update to 2021 Directory of Health Plans Now Available

MMIT has released an updated Directory of Health Plans that reflects key second-quarter trends, including shifting enrollment numbers, acquisitions,… Read more

Employer Healthcare Costs Will Increase 5% in 2022 as the COVID-19 Pandemic Continues

A recent report released by Willis Towers Watson notes an expected 5% increase in healthcare costs in 2022. Premiums and employer premium… Read more

Best Buy Acquires Current Health in Healthcare Strategy

Best Buy has announced its acquisition of Current Health, a remote healthcare management platform that streamlines data collection via digital… Read more

Fierce JPM Week Partner Content Hub

This is a different approach to enabling our partners to share solutions and stories with you in a virtual environment. Here at Fierce JPM Week… Read more

Panalgo’s IHD Platform to Be Used by the EU Medicines Agency for Real-World Data Analytics

Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines… Read more

Text

Study: No Confirmed Benefit of Hydroxychloroquine or Chloroquine in Treatment of COVID-19

Researchers in a recent study were unable to confirm any benefits of hydroxychloroquine or chloroquine in the treatment of COVID-19. "This… Read more

Report: Race-Blind Algorithm Favored White Patients

Researchers say a race-blind algorithm developed by Optum favored white patients over sick black patients, Washington Post reports. According to… Read more

Partners

The Latest Blogs from tHEORetically Speaking

Latest Stories

Global Tumour Necrosis Factor Inhibitor Drugs Market to be Driven by Prevalence of Several Inflammatory Disorders, and Growing Demand Amongst the Geriatric Population in the Forecast Period of 2021-2026

Advertising Driven Press Release Distribution The new report by Expert Market Research titled, ‘Global Tumour Necrosis Factor Inhibitor Drugs Market… Read more

Genedata has Successfully Collaborated with Egis Pharmaceuticals PLC to Develop a Precision Medicine Tool for Rheumatoid Arthritis

With the scientific support of Genedata and its Genedata Profiler® software, Egis has developed the PREDYSTIC® Infliximab RA Kit to guide the… Read more

A return to the top: Former FDA Commissioner Califf reportedly Biden’s pick for Woodcock’s role

A return to the top: Former FDA Commissioner Califf reportedly Biden's pick for Woodcock's role klahucik Thu, 10/14/2021 - 13:52 Read the… Read more

Novartis exec says COVID exposed pharma manufacturing weaknesses. Here’s how he plans to fix them

Novartis exec says COVID exposed pharma manufacturing weaknesses. Here's how he plans to fix them esagonowsky Wed, 10/13/2021 - 15:26 Read the… Read more

HEOR Feature

Using RWE to Make Cost Decisions: A New Report

Featured

MMIT’s Q2 Update to 2021 Directory of Health Plans Now Available

Employer Healthcare Costs Will Increase 5% in 2022 as the COVID-19 Pandemic Continues

Best Buy Acquires Current Health in Healthcare Strategy

Top Stories In HEOR

Fierce JPM Week Partner Content Hub

Panalgo’s IHD Platform to Be Used by the EU Medicines Agency for Real-World Data Analytics

Text

Study: No Confirmed Benefit of Hydroxychloroquine or Chloroquine in Treatment of COVID-19

Report: Race-Blind Algorithm Favored White Patients

Partners

The Latest Blogs from tHEORetically Speaking

Latest Stories

Global Tumour Necrosis Factor Inhibitor Drugs Market to be Driven by Prevalence of Several Inflammatory Disorders, and Growing Demand Amongst the Geriatric Population in the Forecast Period of 2021-2026

Genedata has Successfully Collaborated with Egis Pharmaceuticals PLC to Develop a Precision Medicine Tool for Rheumatoid Arthritis

A return to the top: Former FDA Commissioner Califf reportedly Biden’s pick for Woodcock’s role

Novartis exec says COVID exposed pharma manufacturing weaknesses. Here’s how he plans to fix them

Other Biopharma News

The Latest Job Listings from the HealthEconomics.com Jobs Portal

HEOR Feature

Featured

Top Stories In HEOR

Text

Partners

The Latest Blogs from tHEORetically Speaking

Latest Stories

Other Biopharma News

Trending

Tags

The Latest Job Listings from the HealthEconomics.com Jobs Portal